Question 1

What is Bicara Therapeutics's short- and long-term operating lease liabilities?

Accepted Answer

Bicara Therapeutics (BCAX) reported short- and long-term operating lease liabilities of -$270K in Q1 2026.

Question 2

How has Bicara Therapeutics's short- and long-term operating lease liabilities changed year-over-year?

Accepted Answer

Bicara Therapeutics's short- and long-term operating lease liabilities decreased by 83.7% year-over-year, from -$147K to -$270K.

Question 3

What does short- and long-term operating lease liabilities mean?

Accepted Answer

Measures the net change in the company's obligations related to operating leases for office or laboratory space. Monitoring this helps investors understand the company's long-term fixed facility commitments and their impact on future cash flow requirements.

Line item	Three Months Ended March 31, 2026	Three Months Ended March 31, 2025
Prepaid expenses and other assets	2,089	4,116
Accounts payable and accrued expenses	11,725	(2,116)
Accounts payable and accrued expenses – related party	(1,354)	3,279
Operating lease liabilities	(270)	(147)
Net cash used in operating activities	(37,508)	(28,106)
Investing activities:
Proceeds from maturities and sales of marketable securities	101,000	—
Purchase of property and equipment	(60)	—

Short- and long-term operating lease liabilities at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Returns & leverage

Where this comes from

FAQ

Ask your AI about Bicara Therapeutics's short- and long-term operating lease liabilities.

Bicara Therapeutics BCAX Short- and long-term operating lease liabilities